Table 5.
PS Implementation and Trimming Range | Treatment Prevalence = 0.2 |
Treatment Prevalence = 0.05 |
||||||
RR | Variancea | MSEb | Coveragec | RR | Variancea | MSEb | Coveragec | |
Crude | 2.86 | 0.006 | 0.131 | 0.0 | 2.98 | 0.015 | 0.169 | 3.6 |
True outcome model | 2.00 | 0.003 | 0.003 | 95.5 | 1.99 | 0.007 | 0.007 | 93.7 |
Outcome model (X1–X6)d | 1.39 | 0.006 | 0.142 | 0.0 | 1.45 | 0.014 | 0.124 | 5.0 |
PS analysesd | ||||||||
PS continuous | ||||||||
Unrestricted | 1.38 | 0.007 | 0.149 | 0.0 | 1.46 | 0.022 | 0.128 | 10.6 |
Restricted | ||||||||
0–100 | 1.38 | 0.007 | 0.149 | 0.0 | 1.49 | 0.018 | 0.109 | 12.0 |
1–99 | 1.63 | 0.006 | 0.049 | 9.6 | 1.62 | 0.015 | 0.061 | 33.4 |
2.5–97.5 | 1.85 | 0.006 | 0.012 | 69.3 | 1.77 | 0.015 | 0.032 | 66.2 |
5–95 | 2.01 | 0.005 | 0.005 | 93.6 | 1.90 | 0.015 | 0.018 | 85.9 |
PS quintiles (Mantel-Haenszel) | ||||||||
Unrestricted | 1.60 | 0.007 | 0.057 | 6.3 | 1.72 | 0.016 | 0.041 | 44.7 |
Restricted | ||||||||
0–100 | 1.59 | 0.007 | 0.062 | 4.8 | 1.69 | 0.015 | 0.046 | 40.8 |
1–99 | 1.75 | 0.006 | 0.024 | 35.2 | 1.77 | 0.014 | 0.031 | 61.6 |
2.5–97.5 | 1.92 | 0.005 | 0.007 | 83.3 | 1.86 | 0.014 | 0.021 | 78.8 |
5–95 | 2.04 | 0.005 | 0.005 | 92.3 | 1.95 | 0.015 | 0.016 | 88.1 |
PS quintiles (standardized mortality ratio) | ||||||||
Unrestricted | 1.53 | 0.008 | 0.084 | 3.1 | 1.69 | 0.016 | 0.047 | 39.4 |
Restricted | ||||||||
0–100 | 1.51 | 0.008 | 0.089 | 2.1 | 1.67 | 0.015 | 0.052 | 34.5 |
1–99 | 1.67 | 0.006 | 0.039 | 17.3 | 1.74 | 0.014 | 0.035 | 57.2 |
2.5–97.5 | 1.87 | 0.006 | 0.011 | 73.2 | 1.83 | 0.014 | 0.023 | 76.0 |
5–95 | 2.02 | 0.005 | 0.005 | 93.4 | 1.93 | 0.015 | 0.016 | 88.0 |
PS matching | ||||||||
Unrestricted | 1.28 | 0.009 | 0.215 | 0.0 | 1.35 | 0.036 | 0.202 | 15.0 |
Restricted | ||||||||
0–100 | 1.28 | 0.009 | 0.214 | 0.0 | 1.35 | 0.035 | 0.201 | 15.0 |
1–99 | 1.53 | 0.008 | 0.084 | 5.1 | 1.59 | 0.035 | 0.096 | 48.3 |
2.5–97.5 | 1.78 | 0.008 | 0.023 | 59.3 | 1.76 | 0.037 | 0.059 | 60.7 |
5–95 | 1.99 | 0.008 | 0.008 | 93.2 | 1.90 | 0.040 | 0.045 | 81.7 |
Inverse probability of treatment weighting | ||||||||
Unrestricted | 1.49 | 0.008 | 0.096 | 8.9 | 1.90 | 0.019 | 0.023 | 92.5 |
Restricted | ||||||||
0–100 | 1.48 | 0.008 | 0.101 | 6.7 | 1.86 | 0.019 | 0.026 | 89.9 |
1–99 | 1.83 | 0.006 | 0.014 | 79.5 | 2.05 | 0.019 | 0.019 | 94.0 |
2.5–97.5 | 2.02 | 0.005 | 0.005 | 96.4 | 2.13 | 0.019 | 0.022 | 92.9 |
5–95 | 2.11 | 0.005 | 0.008 | 90.2 | 2.18 | 0.020 | 0.026 | 90.7 |
Abbreviations: MSE, mean squared error; PS, propensity score; RR, rate ratio.
Variance of treatment effect estimates [log(RR)] over 1,000 simulated data sets.
Mean of [log(RR) – log(2.0)]2 over 1,000 simulated data sets.
Percentage of simulated studies in which the 95% confidence interval includes the true value (RR = 2.0).
Outcome and PS models including all measured covariates X1–X6 but not including unmeasured covariate X7.